-
1
-
-
0034920256
-
-
For reviews on chemical genetics, see: (a) MacBeath, G. Genome Biol. 2001, 2, 2005.1.
-
For reviews on chemical genetics, see: (a) MacBeath, G. Genome Biol. 2001, 2, 2005.1.
-
-
-
-
4
-
-
51449096574
-
-
The complementary approach, reverse chemical genetics, involves modulating a known protein and analyzing the resulting phenotype.1b
-
1b
-
-
-
-
5
-
-
46149125638
-
-
For reviews on DOS, see: a
-
For reviews on DOS, see: (a) Spandl, R. J.; Thomas, G. L.; Diaz-Gavilan, M.; O'Connell, K. M. G.; Spring, D. R. Chem. Rec. 2008, 129.
-
(2008)
Chem. Rec
, pp. 129
-
-
Spandl, R.J.1
Thomas, G.L.2
Diaz-Gavilan, M.3
O'Connell, K.M.G.4
Spring, D.R.5
-
7
-
-
41149097628
-
-
(c) Spandl, R. J.; Spring, D. R.; Bender, A. Org. Biomol. Chem. 2008, 6, 1149.
-
(2008)
Org. Biomol. Chem
, vol.6
, pp. 1149
-
-
Spandl, R.J.1
Spring, D.R.2
Bender, A.3
-
9
-
-
33751060195
-
-
(e) Thomas, G. L.; Wyatt, E. E.; Spring, D. R. Curr. Opin. Drug Discovery Dev. 2006, 9, 700.
-
(2006)
Curr. Opin. Drug Discovery Dev
, vol.9
, pp. 700
-
-
Thomas, G.L.1
Wyatt, E.E.2
Spring, D.R.3
-
10
-
-
35949000935
-
-
For reviews and approaches to solving the target identification problem, see: a
-
For reviews and approaches to solving the target identification problem, see: (a) Ahn, Y. H.; Chang, Y. T. Acc. Chem. Res. 2007, 40, 1025.
-
(2007)
Acc. Chem. Res
, vol.40
, pp. 1025
-
-
Ahn, Y.H.1
Chang, Y.T.2
-
11
-
-
41149173665
-
-
(b) Wong, C. C.; Cheng, K. W.; He, Q. Y.; Chen, F. Proteomics: Clin. Appl. 2008, 2, 338.
-
(2008)
Proteomics: Clin. Appl
, vol.2
, pp. 338
-
-
Wong, C.C.1
Cheng, K.W.2
He, Q.Y.3
Chen, F.4
-
12
-
-
2642573570
-
-
(c) Zheng, X. F. S.; Chan, T. F.; Zhou, H. H. Chem. Biol. 2004, 11, 609.
-
(2004)
Chem. Biol
, vol.11
, pp. 609
-
-
Zheng, X.F.S.1
Chan, T.F.2
Zhou, H.H.3
-
14
-
-
37349009631
-
-
For reviews of quorum sensing involving N-acylated homoserine lactones, see: a
-
For reviews of quorum sensing involving N-acylated homoserine lactones, see: (a) Hodgkinson, J. T.; Welch, M.; Spring, D. R. ACS Chem. Biol. 2007, 2, 715.
-
(2007)
ACS Chem. Biol
, vol.2
, pp. 715
-
-
Hodgkinson, J.T.1
Welch, M.2
Spring, D.R.3
-
15
-
-
45749124990
-
-
(b) Geske, G. D.; Oneill, J. C.; Miller, D. M.; Wezeman, R. J.; Mattmann, M. E.; Lin, Q.; Blackwell, H. E. ChemBioChem 2008, 9, 389.
-
(2008)
ChemBioChem
, vol.9
, pp. 389
-
-
Geske, G.D.1
Oneill, J.C.2
Miller, D.M.3
Wezeman, R.J.4
Mattmann, M.E.5
Lin, Q.6
Blackwell, H.E.7
-
16
-
-
33645527331
-
-
For selected recent examples, see: a
-
For selected recent examples, see: (a) Thomas, G. L.; Bohner, C. M.; Williams, H. E.; Walsh, C. M.; Ladlow, M.; Welch, M.; Bryant, C. E.; Spring, D. R. Mol. BioSyst. 2006, 2, 132.
-
(2006)
Mol. BioSyst
, vol.2
, pp. 132
-
-
Thomas, G.L.1
Bohner, C.M.2
Williams, H.E.3
Walsh, C.M.4
Ladlow, M.5
Welch, M.6
Bryant, C.E.7
Spring, D.R.8
-
17
-
-
26644444285
-
-
(b) Welch, M.; Mikkelsen, H.; Swatton, J. E.; Smith, D.; Thomas, G. L.; Glansdorp, F. G.; Spring, D. R. Mol. BioSyst. 2005, 1, 196.
-
(2005)
Mol. BioSyst
, vol.1
, pp. 196
-
-
Welch, M.1
Mikkelsen, H.2
Swatton, J.E.3
Smith, D.4
Thomas, G.L.5
Glansdorp, F.G.6
Spring, D.R.7
-
18
-
-
23944467542
-
-
(c) Welch, M.; Dutton, J. M.; Glansdorp, F. G.; Thomas, G. L.; Smith, D. S.; Coulthurst, S. J.; Barnard, A. M. L.; Salmond, G. P. C.; Spring, D. R. Bioorg. Med. Chem. Lett. 2005, 15, 4235.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, pp. 4235
-
-
Welch, M.1
Dutton, J.M.2
Glansdorp, F.G.3
Thomas, G.L.4
Smith, D.S.5
Coulthurst, S.J.6
Barnard, A.M.L.7
Salmond, G.P.C.8
Spring, D.R.9
-
19
-
-
10244250426
-
-
(d) Glansdorp, F. G.; Thomas, G. L.; Lee, J. J. K.; Dutton, J. M.; Salmond, G. P. C.; Welch, M.; Spring, D. R. Org. Biomol. Chem. 2004, 2, 3329.
-
(2004)
Org. Biomol. Chem
, vol.2
, pp. 3329
-
-
Glansdorp, F.G.1
Thomas, G.L.2
Lee, J.J.K.3
Dutton, J.M.4
Salmond, G.P.C.5
Welch, M.6
Spring, D.R.7
-
20
-
-
0029878107
-
-
A solution-phase route to OHHL(2) : Dekhane, M.; Douglas, K. T.; Gilbert, P. Tetrahedron Lett. 1996, 37, 1883.
-
A solution-phase route to OHHL(2) : Dekhane, M.; Douglas, K. T.; Gilbert, P. Tetrahedron Lett. 1996, 37, 1883.
-
-
-
-
21
-
-
35548936536
-
-
The synthesis of native N-acylated homoserine lactones [including OHHL(2)] and non-natural analogues on solid support: (a) Geske, G. D.; O'Neill, J. C.; Blackwell, H. E. ACS Chem. Biol. 2007, 2, 426.
-
The synthesis of native N-acylated homoserine lactones [including OHHL(2)] and non-natural analogues on solid support: (a) Geske, G. D.; O'Neill, J. C.; Blackwell, H. E. ACS Chem. Biol. 2007, 2, 426.
-
-
-
-
22
-
-
35948991561
-
-
(b) Geske, G. D.; O'Neill, J. C.; Miller, D. M.; Mattmann, M. E.; Blackwell, H. E. J. Am. Chem. Soc. 2007, 129, 13613.
-
(2007)
J. Am. Chem. Soc
, vol.129
, pp. 13613
-
-
Geske, G.D.1
O'Neill, J.C.2
Miller, D.M.3
Mattmann, M.E.4
Blackwell, H.E.5
-
23
-
-
25144448174
-
-
(c) Geske, G. D.; Wezeman, R. J.; Siegel, A. P.; Blackwell, H. E. J. Am. Chem. Soc. 2005, 127, 12762.
-
(2005)
J. Am. Chem. Soc
, vol.127
, pp. 12762
-
-
Geske, G.D.1
Wezeman, R.J.2
Siegel, A.P.3
Blackwell, H.E.4
-
24
-
-
0037413582
-
-
Analogues of the related signaling molecule N-3- (oxododecanoyl)-L-homoserine lactone (OdDHL), used in Pseudomonas aeruginosa, have been synthesized by coupling using the acid, Meldrum's acid, and the amine in one pot: Chhabra, S. R.; Harty, C.; Hooi, D. S. W.; Daykin, M.; Williams, P.; Telford, G.; Pritchard, D. I.; Bycroft, B. W. J. Med. Chem. 2003, 46, 97; in our hands this method proved less fruitful than the stepwise method employed therein.
-
Analogues of the related signaling molecule N-3- (oxododecanoyl)-L-homoserine lactone (OdDHL), used in Pseudomonas aeruginosa, have been synthesized by coupling using the acid, Meldrum's acid, and the amine in one pot: Chhabra, S. R.; Harty, C.; Hooi, D. S. W.; Daykin, M.; Williams, P.; Telford, G.; Pritchard, D. I.; Bycroft, B. W. J. Med. Chem. 2003, 46, 97; in our hands this method proved less fruitful than the stepwise method employed therein.
-
-
-
-
25
-
-
51449120400
-
-
N-(3-Oxohexanoyl)-L-homoserine lactone(2, R f, 0.23 (SiO2; EtOAc-PE, 8:2, IR (neat, νmax, 3301 (w, br, 2965 (w, 2878 (w, 1774 (s, 1716 (m, 1649 (s, 1535 (m, 1379 (m, 1221 (m, 1169 (s, 1021 (m) cm-1. 1H NMR (400 MHz, CDCl3, δ, 7.73 (1 H, br s, CONH, 4.63-4.51 [1 H, br m, C(2)H, 4.43 [1 H, br t, J, 9.1 Hz, C(4)H aHb, 4.27-4.18 [1 H, br m, C(4)HaH b, 3.42 (2 H, s, COCH2CO, 2.68-2.58 [1 H, br m, C(3)HaHb, 2.47 (2 H, t, J, 7.3 Hz, CH 3CH2CH2, 2.30-2.16 [1 H, br m, C(3)H aHb, 1.54(2 H, sext, J, 7.3 Hz, CH 3CH2CH2, 0.86 (2 H, t, J, 7.5, CH 3CH2CH2, 13C NMR (100 MHz, CDCl3, δ, 206.1 (C, 175.2 (C, 166.9 C, 65.9
-
3).
-
-
-
-
26
-
-
51449098515
-
-
Blackwell, H. E.; Geske, G. D.; Wezeman, R. J. WO 2006/084056 A2, 2006.
-
Blackwell, H. E.; Geske, G. D.; Wezeman, R. J. WO 2006/084056 A2, 2006.
-
-
-
-
27
-
-
51449096778
-
-
3). Although some racemization may have occurred during the synthesis reported here, this did not affect binding of CarR. In our hands coupling with HOBt was less successful.
-
3). Although some racemization may have occurred during the synthesis reported here, this did not affect binding of CarR. In our hands coupling with HOBt was less successful.
-
-
-
-
28
-
-
51449115180
-
-
Polymer-bound DMAP was required in the final EDC-mediated coupling to aid purification. The reaction products and DMAP had very similar R f values. Synthesis of 18 A round-bottom flask, equipped with a magnetic stirrer, containing the ester 17 (529 mg, 1.02 mmol, LiOH·H2O (98 mg, 2.33 mmol) and 66% aq MeOH (25 mL) was stirred at r.t. for 16 h. The solvent was removed in vacuo to give the lithium salt of the corresponding acid (structure not shown) as a white solid (550 mg, The salt was used in subsequent reactions without further purification. A round-bottom flask, equipped with a magnetic stirrer, containing the lithium salt (0.55 g, 1.09 mmol, EDC (0.27 g, 1.42 mmol, polymer-bound DMAP (5 mmol/g, 1.1 g, 5.46 mmol, and DMF (40 mL) was stirred at r.t. for 15 min before being charged with L-homoserine lactone hydrobromide (1.02 g, 5.6 mmol) and stirred at r.t. for 16 h. The crude reaction mixture was filtered and solvent removed in vacuo
-
2).
-
-
-
|